Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophils
- 30 September 1984
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 74 (3), 296-301
- https://doi.org/10.1016/0091-6749(84)90261-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Gold-induced reduction in reactivity to histamine in isolated guinea pig tracheal ringsJournal of Allergy and Clinical Immunology, 1983
- Role of Phospholipase A2 Activation in Histamine Release from Human BasophilsAllergy, 1983
- Auranofin. New oral gold compound for treatment of rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1976
- A Controlled Trial of Gold Salt Therapy in Rheumatoid ArthritisArthritis & Rheumatism, 1973
- Gold Treatment in Rheumatoid ArthritisAnnals Of The Rheumatic Diseases, 1945
- THE TREATMENT OF RHEUMATOID ARTHRITIS WITH GOLD SALTS INJECTIONS.The Lancet, 1932